MED
MEDIFAST INC
12.20$
+2.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -19.0% | -8.5% | -3.5% | -16.8% | -15.1% | -2.8% | -8.8% | -15.3% | -16.0% | +1.3% | +0.4% | – | |
| – | -15.1% | -4.4% | -4.9% | -23.6% | -10.7% | +2.3% | -8.2% | -5.7% | -15.8% | +5.8% | -5.4% | – | |
| – | -20.3% | -10.0% | -3.0% | -14.4% | -16.5% | -4.5% | -9.0% | -18.9% | -16.1% | -0.7% | +3.2% | – | |
| – | -7.7% | -16.7% | +10.0% | +0.0% | – | – | – | – | – | – | +0.0% | – | |
| – | -14.1% | -7.7% | +10.0% | -21.1% | -15.5% | -2.3% | -12.3% | -11.7% | -11.0% | -6.6% | +4.9% | – | |
| – | -12.6% | -10.1% | +10.0% | -21.1% | -15.5% | -2.3% | -9.1% | -14.8% | -9.5% | -11.8% | +9.2% | – | |
| – | -66.0% | -8.5% | -199.2% | – | -66.3% | -278.0% | – | – | – | – | – | – | |
| – | – | – | – | – | -82.1% | +69.0% | -100.0% | – | – | – | – | – | |
| – | -63.1% | +18.2% | -191.9% | – | -19.2% | -58.7% | +446.6% | -192.4% | – | – | – | – | |
| – | +10.2% | -13.2% | -176.4% | – | +5.6% | +173.8% | -69.6% | -200.3% | – | -98.5% | -39.8% | – | |
| – | -73.9% | +37.8% | -198.1% | – | -29.1% | -196.4% | – | -191.2% | – | – | – | – | |
| – | -56.1% | +12.9% | -151.1% | – | -6.5% | -14.7% | +81.8% | -88.5% | -466.9% | – | -294.0% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.